Fesoterodine Fumarate Tablet, Film Coated, Extended Release
Product Images NDC 70771-1169

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fesoterodine Fumarate (NDC 70771-1169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fesoterodine Er Tablets, 4 mg (9b26e45d Eef8 463b 9773 9ce326ecb333 06)

Fesoterodine fumarate extended-release tablets, 4 mg strength, film-coated oral tablets. The label shows the Zygenerics logo and an NDC number 70771-1168-9. The package contains 90 tablets for prescription use only. Manufacturer is Cadila Healthcare Ltd., Ahmedabad, India. Additional storage and usage information is provided on the label.*

FDA Label Image

Fesoterodine Er Tablets, 8 mg (9b26e45d Eef8 463b 9773 9ce326ecb333 07)

Label for fesoterodine fumarate extended-release tablets, 8 mg strength, manufactured by Zydus Lifesciences Limited. The label indicates 90 film-coated tablets for oral use, prescription only. Instructions include pharmacist dispensing patient information separately, usual dosage reference, storage conditions at 20° to 25°C, and caution to keep out of reach of children. Manufacturer listed as Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.